Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of Marc Ostro
 

Marc Ostro

 
MD, Biotechnology, TL Ventures, Member, Scientific, Member - Clinical Advisory Board - Sopherion Therapeutics Inc.
 
Marc Ostro Email :
Please login
 
Company Name : Sopherion Therapeutics Inc.
 
Company Website : www.sopherion.com
 
Company Address : 104 Carnegie Ctr.
Ste. 200, Princeton, NJ,
United States,
 
Marc Ostro Profile :
MD, Biotechnology, TL Ventures, Member, Scientific, Member - Clinical Advisory Board - Sopherion Therapeutics Inc.
 
Marc Ostro Biography :

Dr. Marc Ostro has considerable experience as a researcher, entrepreneur, company executive, Wall Street analyst and financial advisor.

After earning a B.S. degree in Biology from Lehigh University in 1971 and his Ph.D. degree in Biochemistry from Syracuse University in 1976, he began studying liposomes as a delivery vehicle, first as a post-doctoral student and then as an Assistant Professor of Immunology and Molecular Biology at the University of Illinois Medical School. Dr. Ostro was the first to use liposomes as vehicles to deliver genetic material into cells. As a result of this work, Dr. Ostro was given a Young Investigator Award by the National Institutes of Health.

In 1981, he commercialized his discoveries by co-founding The Liposome Company, one of the earliest biotechnology companies. The Liposome Company-for which Dr. Ostro served as President, Vice Chairman, and Chief Science Officer-was sold for over $700 million in 1999. He played a key role in raising approximately $200 million in equity financing for the Company in three private and five public offerings. While he was at the Liposome Company, he also helped orchestrate four spin-offs and joint ventures, negotiated numerous licensing agreements with pharmaceutical companies in the United Stated, Europe and Japan, and led a research team that successfully developed two cancer- related products that are now on the market.

Throughout the 1980's Dr. Ostro was a pioneer in both the science and business of biotechnology. He founded the Journal of Liposome Research and was involved in editing similar peer-reviewed journals, edited two books on liposomes and authored more than 30 articles on drug delivery while sitting on four scientific advisory boards and organizing numerous international conferences. He holds twelve patents in the U.S. and Europe and was an expert witness for the Senate subcommittee on Patents and Trademarks. Dr. Ostro continued in his pioneering role in the Biotechnology industry when, in 1993, he took his expertise to Wall Street to become the first biotechnology equity analyst with senior biotechnology management experience. He began with Mabon Securities (1993-1994), where he initiated and grew the firm's biotechnology practice. Later, as a Managing Director and a leader of UBS Securities biotech analyst group (1994-1997), he played an influential role in the biotech public markets. At UBS, he was involved in numerous IPOs and secondary offerings.

As Senior Vice President of Ross Financial Corporation (1997), a wholly owned subsidiary of Kenneth Dart, he was charged with making sizeable, long-term, pro-active biotech investments for Dart's portfolio. As Senior Managing Director and Head of KPMG's Life Science Group (1997-2000), he was involved in mergers, acquisitions, private placements for public and private biotechnology companies, in and out licensing of products, and general financial, operational, and technical consulting. While at KPMG, Dr. Ostro also authored three articles on the rationale for mergers within the biotechnology industry.

Dr. Ostro has served on the Board of Directors of nine biotech companies. Dr. Ostro currently serves on the Board of Directors of Polymerix Inc., Heartland Payment Systems and Sopherion Therapeutics, Inc. Dr. Ostro is also on the Board of Trustees of Princeton Day School.

 
Marc Ostro Colleagues :
Name Title Email

Ronald Goldfarb

Dir., CEO, Chief Scientific Officer, Pres. Please login

Salvatore Forenza

VP - Research, Development Please login

Elizabeth Harris

VP - Commercial Operations Please login

James O'Brien

Chief Medical Officer, VP - Clinical Development, Medical Affairs Please login

Gregory Patrick

CFO Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.